Hand-held Surgical Instruments Market Size, Share & Trends Analysis Report By Product (Forceps, Retractors, Dilators, Graspers, Scalpels, Cannulas, Dermatome, Trocars, Others), By Application (Neurosurgery, Orthopaedic, Plastic & Reconstructive Surgery, Obstetrics, Orthopedic Surgery, Cardiology, Ophthalmology, Wound Care, Audiology, Thoracic Surgery, Urology & Gynecology Surgery, Plastic Surgery, Others), By End-Users (Hospitals, Clinics, Ambulatory Surgical Centres, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Market Overview

The global hand-held surgical instruments market size was valued at USD 5.12 billion in 2021, and it is anticipated to reach USD 9.62 billion by 2030 at a CAGR of 7.26%.

Hand-held surgical instruments are the types of medical devices that are utilized in the process of performing a variety of surgical procedures. Hand-held surgical devices are utilized most frequently in minimally invasive surgical procedures, such as precise incision and post-surgery procedures. Hand-held surgical instruments are made of high-grade stainless steel, the most notable characteristic of these devices.

One of the primary factors contributing to the expansion of the hand-held surgical instruments market share is the rising prevalence of aesthetic procedures. The rising frequency of neurological disorders is also driving this trend. Other factors indirectly responsible for expanding the portable surgical instruments market include increased expenditures on research & development efforts for new developments and rising personal disposable income. Hand-held surgical equipment could benefit from an increase in traffic accidents, particularly in developing economies, as well as an increase in the number of elderly people. The expansion of programs geared toward the education of women and the rising awareness of issues relating to women's health are contributing factors to the expansion of the market.

Market Dynamics

Market driving factors

Increasing numbers of people opting for cosmetic surgery

The rising prevalence of neurological conditions is one of the primary forces initially driving the expansion of the market for hand-held surgical equipment. Other indirect factors contributing to market expansion include rising personal disposable income and increased spending on research and development activities related to product improvements. The market is growing due to a rise in the number of activities targeted at educating women and a better awareness of the importance of women's health.

Increase in the total number of operations

The need for cosmetic operations will serve as the primary impetus for expanding the market for hand-held surgical tools during the next several years. In addition, the rapidly growing older population will substantially contribute to the industry's revenue in the coming years. In addition, developments in instrument design and interface design will assist medical professionals in getting the most out of their devices, which will fuel the expansion of the market.

Global hand-held surgical instruments market opportunities

The growing number of road accidents

Numerous surgical operations are carried out daily in each region of the world. It is another factor expected to be a driving force in the sector over the following years. The growing number of car accidents, particularly those in developing countries, in conjunction with an ageing population, would generate lucrative opportunities for developing the market for hand-held surgical devices. The expansion of programs that focus on educating women and raising awareness about the importance of women's health are both factors driving the market growth.

Market restraining factors

Competitive pricing

The market for hand-held surgical equipment will be constrained by the intense competition in pricing among the various producers. Because an increasing number of regional manufacturers are providing hand-held surgical instruments at lower prices offered by big global manufacturers, businesses are forced to engage in intense price competition. As a result, they frequently require significant sales volumes to succeed.

Regional Analysis

The market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

As chronic diseases like cardiovascular disease, neurological disease, cancer, diabetes, and autoimmune disease become more prevalent across the region, the market is expanding.

The prevalence of chronic diseases in Canada, such as cancer, neurological, musculoskeletal, and cardiovascular diseases, has been on the rise, which has had a significant positive impact on the market. Several other essential variables are contributing to the expansion of the market in the country, including an increase in the incidence of burn injuries, trauma cases, and surgical procedures. According to the World Health Organization (WHO), non-communicable diseases like diabetes, chronic respiratory diseases, cancer, and cardiovascular diseases are responsible for more than 88 per cent of fatalities in Canada. These statistics provide evidence of an increase in the number of surgical procedures carried out. As a result, it is estimated that the factors mentioned above will drive up demand for portable surgical tools, which, in turn, will likely push the market expansion in the area.

The World Health Organization (WHO) reports that the burden of non-communicable illnesses is highest in Europe, and it is anticipated to continue to increase rapidly in the foreseeable future. As a result of increased surgical procedures, there has been a greater need to get medical equipment in the area. The increasing proportion of senior people in Asia and the Pacific is one of the key factors driving growth in the region's industry.

Segmental Analysis

The global hand-held surgical instruments market is divided into four parts based on product types, applications, end-users, and region.

Further, based on the product type, the market is divided into scalpels, forceps, retractors, dilators, and graspers. Scalpels, forceps, scissors, and retractors are often crafted from premium stainless steel and come in a wide range of sizes, styles, and shapes that are appropriate for various surgical procedures. Europe and Asia are the leading manufacturing regions for these instruments.

Neurosurgery, cardiovascular, orthopaedic, plastic & reconstructive surgery, gynaecology & obstetrics, and others comprise the hand-held surgical instruments market's application segment. Gynaecology & obstetrics is one of these, and it is predicted that they will account for a significant portion of the market for hand-held surgical equipment over the forecast period. Some key drivers driving the expansion of the gynaecology & obstetrics market include an increase in initiatives for women's education, an increase in the number of senior women experiencing postmenopausal difficulties, and awareness of women's health. Due to growing interest in skin rejuvenation, rising rates of skin cancer, rising per capita income, and technical developments in the industry, the plastic and reconstructive surgery segment are anticipated to rise significantly throughout the forecast period.

According to end-users, the market is divided into hospitals, specialized clinics, long-term care centres, and ambulatory surgery centres. The hospital segment dominates the market.

Based on region, the market is broken down into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America dominates the market.

Recent Developments

• In February 2022, the CORI Surgical System, a next-generation hand-held robotics platform from Smith + Nephew, a multinational company in the medical technology sector, made its commercial debut in Japan.
• In May 2022, the Johnson & Johnson subsidiary received a second FDA approval for its Monarch robotic surgery system, allowing it to be used in kidney stone removal treatments.
• In May 2022, BD (Becton, Dickinson, and Company), a global leader in medical technology, announced the debut of their new, fully automated, high-throughput infectious disease molecular diagnostics platform in the United States.